Rxo (RXO) Accumulated Depreciation & Amortization (2021 - 2025)

Rxo (RXO) has 5 years of Accumulated Depreciation & Amortization data on file, last reported at $116.0 million in Q4 2025.

• For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 33.33% year-over-year to $116.0 million; the trailing twelve-month figure through Dec 2025 stood at $116.0 million (up 33.33% YoY), and the FY2025 full-year result was $116.0 million, up 33.33% from the prior year.
• Accumulated Depreciation & Amortization for Q4 2025 stood at $116.0 million, up from $87.0 million in the prior quarter.
• Across five years, Accumulated Depreciation & Amortization topped out at $116.0 million in Q4 2025 and bottomed at $52.0 million in Q3 2023.
• The 5-year median for Accumulated Depreciation & Amortization is $81.0 million (2021), against an average of $77.6 million.
• The widest annual swing landed in 2023, when Accumulated Depreciation & Amortization slipped 22.09%; it then jumped 33.33% in 2025.
• A 5-year view of Accumulated Depreciation & Amortization shows it stood at $81.0 million in 2021, then increased by 6.17% to $86.0 million in 2022, then fell by 22.09% to $67.0 million in 2023, then rose by 29.85% to $87.0 million in 2024, then surged by 33.33% to $116.0 million in 2025.
• The last three Accumulated Depreciation & Amortization figures came in at $116.0 million (Q4 2025), $87.0 million (Q4 2024), and $54.0 million (Q3 2024), per Business Quant data.

Peer Comparison